Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis
about
Endothelial progenitor cells: what use for the cardiologist?Endothelial progenitor cell capture stents versus drug-eluting stents for angina or acute coronary syndromeGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionPercutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(-) cellsPericardial patch angioplasty heals via an Ephrin-B2 and CD34 positive cell mediated mechanismDiabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.Association between high-density lipoprotein-cholesterol and hypertension in relation to circulating CD34-positive cell levels.Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteriesCD34 affinity pheresis attenuates a surge among circulating progenitor cells following vascular injury.Microelectromechanical systems and nanotechnology: a platform for the next stent technological era.E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1α/CXCR4.Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion.Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model.Association between microalbuminuria predicting in-stent restenosis after myocardial infarction and cellular senescence of endothelial progenitor cellsVascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.The A2b adenosine receptor protects against vascular injury.Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodelingNeo-intimal hyperplasia, diabetes and endovascular injury.Drug-eluting stents - what should be improved?Pharmacological approaches to improve endothelial repair mechanisms.Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competenceTransplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.Cell-based methods for ex vivo evaluation of human endothelial biology.Vascular smooth muscle cell motility: From migration to invasion.Restenosis after PCI. Part 2: prevention and therapy.Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting.Biocompatibility of Coronary Stents.Endothelial progenitor cells mobilisation after percutaneous coronary intervention: a pilot study.Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent.Local insulin application on the carotid artery inhibits neointima formation.Endothelial Progenitor Cell Biology and Vascular Recovery Following Transradial Cardiac Catheterization.Vascular Calcification: Is it rather a Stem/Progenitor Cells Driven Phenomenon?Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.Phenotype and differentiation of bone marrow-derived smooth muscle progenitor cells.The late-phase inflammatory response after drug-eluting stent implantation.Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents.Mobilization of progenitor cells and assessment of vessel healing after second generation drug-eluting stenting by optical coherence tomography.Long-Term Effects of Novel Combination Coating Anti-CD34 Antibody Applied on Sirolimus-Eluting Stents.
P2860
Q21198698-417520B3-55C5-43BA-8026-80FA492B2E66Q24202607-823B4D02-F9EB-4EA6-A9CD-6940DFCDB5D6Q24568374-0F37E689-DD53-496E-BFE1-35CD65D20FB0Q28654918-A3D61A5B-0AA4-4846-B7E2-686EEDE21B2DQ28728533-FAF21CE8-19F3-476C-BF6E-92B76DF93A08Q33649275-E92C44E3-9703-46C2-B400-3EA3D06A42F8Q33776274-62C6E77D-6D54-4F38-B280-9E5643ABA2DDQ33805068-754FC373-7E13-49DA-8277-2621C696F45DQ33808599-B2DBF4D0-1B81-441E-942A-EC04A97FED7AQ34186552-2F8833FB-14D0-437E-A5FB-98503709BB68Q34304812-753BAC1E-6AB6-4CC7-B649-457CC256CDDEQ34658637-D5C9E606-84AD-470B-9815-44D0C797A8ACQ34724214-384B4FFD-5F7C-4644-B404-D8AADD300A1CQ35079541-A77D2333-47B8-4C06-9BF5-509B78DA880FQ35392119-11A9B4E6-3603-41A1-9A6C-4233CF1EEA61Q35927338-30B29681-6644-4DE0-8BDC-921563C1C23AQ36242530-090E6A10-8B24-45DE-AF9A-3C8367D10700Q36393058-3D1A7634-96B1-46A3-B713-D980B4B296B3Q36960275-CCA78AD8-C97C-47B6-A6D1-A556D1A2AAD1Q37041823-2D27C426-EAF7-486C-9D08-E9509D6D3755Q37144221-BA772D81-AFB6-4734-97CD-84A62444E4D0Q37269376-C8E90080-D23B-45A9-A550-64C0EE55BBE6Q37293820-1C67026E-8173-4F2A-8B25-8C77568E2AF9Q37570669-B04E3C76-A59E-4B42-A9D2-56DBAADB0597Q37739010-9CFAEE37-56AB-4A26-B174-D6284B182208Q37832151-93F82779-3C17-412B-98C4-C41976C73BDBQ37944416-F6353A91-54B7-4150-AF9C-17C8C891C4F7Q39781636-9F986764-8605-4E98-B8BD-41DCFD473372Q42232032-3A6A773F-1DEB-45E8-A7EE-A64C8DAB9712Q42494769-343A87E0-8D87-44EE-8F43-E339098C5F5EQ44941164-075247B3-55D4-4367-8D90-B9156B3941D8Q46832582-5A93285A-C3C9-4839-BF2C-825D3ACF23B2Q47126850-96E76E3A-C705-4BA2-A282-E30DD6DBCC3DQ50300607-D68DB0F2-8B6F-4758-9D3D-46D93257CB4EQ50462523-75481882-4E0B-40EF-8D16-0305E24D6C46Q50518644-1EC3CE4A-CDEB-40A3-9BCB-723E9B79490CQ51014960-6A30CD49-EC55-458B-9108-51877066A3A6Q51806831-E4D06B5B-26BC-4537-89DF-1A392EFE8146Q52647550-54FBA7A3-A164-4845-A1E3-A7109A3195AFQ53230722-5B7941C6-AFF7-485F-BB68-E1796720A202
P2860
Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mobilization of CD34-positive ...... antation: impact on restenosis
@ast
Mobilization of CD34-positive ...... antation: impact on restenosis
@en
Mobilization of CD34-positive ...... antation: impact on restenosis
@en-gb
Mobilization of CD34-positive ...... antation: impact on restenosis
@nl
type
label
Mobilization of CD34-positive ...... antation: impact on restenosis
@ast
Mobilization of CD34-positive ...... antation: impact on restenosis
@en
Mobilization of CD34-positive ...... antation: impact on restenosis
@en-gb
Mobilization of CD34-positive ...... antation: impact on restenosis
@nl
prefLabel
Mobilization of CD34-positive ...... antation: impact on restenosis
@ast
Mobilization of CD34-positive ...... antation: impact on restenosis
@en
Mobilization of CD34-positive ...... antation: impact on restenosis
@en-gb
Mobilization of CD34-positive ...... antation: impact on restenosis
@nl
P2093
P921
P1433
P1476
Mobilization of CD34-positive ...... antation: impact on restenosis
@en
P2093
Daiju Fukuda
Hiroshi Komoda
Koichi Node
Masataka Sata
Minoru Shimizu
Ryoichi Sohma
Teruo Inoue
Toshihiko Uchida
Yutaka Hikichi
P304
P356
10.1161/CIRCULATIONAHA.106.621714
P407
P577
2007-02-06T00:00:00Z